Automate Biopharma Compliance | Global E-Invoicing Solutions

Pharmaceutical and biomedical organizations have a worldwide presence. When it comes to keeping up with invoicing compliance, their operations are further complicated by their global nature. There is, however, one clear way to simplify compliance with worldwide requirements—automation.

Compliance is complicated…leave it to the pros

The regulations around electronic invoicing (e-invoicing) and electronic archiving (e-archiving) vary vastly between countries. And regulatory guidance and practical interpretations are not always clear. The water further muddies for global industries such as pharmaceutical and biomedical (biopharma).

In practice, biopharma organizations need to understand a wide range of local and cross-border requirements, design solutions to meet those requirements, and continually manage change as the regulatory environment evolves. It is a full-time job—often more—that most biopharma firms do not have the bandwidth to take on. These organizations should be able to focus their resources on researching and developing the next medical innovations, not sifting through a constant barrage of global mandates and determining the best ways to remain compliant with ever-changing requirements.

To put it lightly, global tax compliance is complex, fragmented, and constantly changing. And since these taxes are a significant source of revenue for many governments, the consequences of non-compliance can be very severe. These can range from fines and protracted audits to sanctions under criminal law. And biopharma firms can’t afford to redistribute funds that are intended for medical research to pay for non-compliance fines.

What this means is that compliance can no longer be an afterthought. In the 1990s, and even up to 2014 or 2015, organizations would define an electronic invoicing strategy and then evaluate whether that strategy might also address compliance. Today, that process has been flipped. For any biopharma organization operating globally, compliance has become a minimum requirement of any procure-to-pay (P2P) automation strategy.

Invoice archiving is another critical area as it is a base requirement everywhere. It is the common denominator for tax compliance. E-invoicing rules vary from country to country, but almost all countries require the “original” of an invoice to be archived and stored away for later audits. And if you have a solid archiving compliance strategy, you’ve covered half the work of achieving tax compliance.

So, biopharma firms have two options: manage the e-invoice and e-archive compliance in-house or let the experts do it for you.

Basware provides biopharma automation solutions from day one

Basware delivers a total e-invoicing solution, assisting you with all your compliance challenges from identifying obligations and assessing requirements to designing and managing solutions and keeping track of all the changes in the regulatory environment.

In other words, we support you in all aspects of e-invoicing compliance.

For years, Basware has been gathering regulatory and best practice knowledge from local markets, building new format conversions, connecting locally authorized compliance partners and tax authorities, and enabling the use of digital signatures and certificates. With this all under our belt, we can support your biopharma firm through all aspects of compliance, covering both B2B and B2G connectivity.

As a global market leader in e-invoicing, Basware is the strongest partner to consider for your global e-invoicing compliance requirements. No matter your needs, Basware helps you cover all e-invoice delivery channels.

We provide a single source for global compliance by providing support in over 60 countries through our 200+ interoperability partners. We deliver multi-channel coverage combined with localised knowledge and connectivity to third parties. 

So, how is it that we can provide all this for biopharma firms worldwide? For starters, we’ve partnered up with the leading e-invoicing and tax compliance advisers and service providers, as well as with various local partners, to ensure our business network supports our customers for compliant e-invoicing where it’s needed the most. On top of that, Basware’s in-house compliance management works together with our service management team as well as with external advisers and authorities to maintain and improve the compliance support provided by the Basware Network.

Our network and its country coverage are constantly expanding, providing firms like yours with complete compliance support. This frees biopharma organizations from the burden and complexity of global compliance and lets you focus on what matters—advancing medical innovation.

As we discussed earlier, complying with global invoicing and tax mandates is complex and the consequences of non-compliance can be severe. But with Basware, you can automate your compliance across all B2G and B2B mandates that include different formats, processes, and archiving standards. You'll never lose sleep over compliance again as Basware supports you in your VAT compliance work in more than 50 countries and a certified PEPPOL access point.

Efficiency, compliance and control—thanks to biopharma automation

At the end of the day, compliance isn’t easy. But when you let the experts support you, you gain efficiency, compliance, and control. 

Efficiency

• Reduce the costs associated with handling global tax compliance.

• Free resources from a large part of the burden and complexity of compliance to focus on core business.

Compliance

• Minimize errors by providing up-to-date tax information.

• Reduce the risk of financial penalties and other sanctions associated with non-compliance with regulations.

Our implementation of biopharma automation approach

Our implementation centers on seamlessly automating biopharma compliance, leveraging advanced e-invoicing and e-archiving solutions tailored for global operations. By partnering with regulatory experts and integrating local market knowledge, our platform keeps pace with worldwide mandates while minimizing manual intervention and errors. This enables biopharma organizations to reduce compliance costs, mitigate risk, and concentrate on medical innovation. End-to-end automation provides reliable connectivity, up-to-date tax compliance, and efficient procurement cycles—freeing resources to focus on what matters most: breakthrough science and global impact.

How we validate biopharma automation

Our validation process blends deep regulatory expertise and real-time oversight, ensuring biopharma automation fulfills every global compliance requirement. By collaborating with accredited advisers and local authorities, we keep pace with shifting mandates while performing multi-layered testing across all touchpoints. Secure archiving of original invoices and regular system updates guarantee audit readiness and reliability. This approach empowers organizations to stay ahead of complex international standards, reduce errors, and maintain business continuity—all while focusing on scientific advancement, confident that compliance is assured.

AI and machine learning

AI and machine learning elevate our automation by intelligently navigating complex compliance landscapes and streamlining data management. These technologies continuously learn from evolving mandates, automatically updating processes and formats to prevent errors and stay audit-ready. Advanced analytics rapidly identify exceptions, reduce manual effort, and optimize workflows, all while ensuring secure, accurate documentation across global channels. For biopharma organizations, this means operational agility, confidence in regulatory alignment, and more time to drive scientific innovation, powered by smart, adaptive automation.

Learn how else automation benefits biopharma

Automation transforms biopharma operations far beyond compliance. Streamline procurement, enhance invoice management, and enable real-time financial insights, allowing teams to focus on critical medical innovation instead of manual paperwork. Explore Basware’s solutions for the biopharma industry to see how automation drives compliance, efficiency, and innovation.